ECJ should uphold Italian enforcer on Roche/Novartis, AG says
Advocate-General Henrik Øe has urged the European Court of Justice to rule in favour of a decision to fine Roche and Novartis for colluding to induce consumers to use a more expensive drug rather than a cheaper off-label alternative, and to confirm the Italian competition enforcer's finding of a by-object restriction of competition.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10